Business · 14/06/2013
FDA Releases Guidance for Industry on Co-Development of New Investigational Combination Drugs
The FDA has made available a guidance document to help pharmaceutical companies collaborate on the development of two or more new investigational drugs to treat a specific disease or condition, in combination with each other.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →